|
27 Nov 2025 |
Inventurus Knowledge
|
Consensus Share Price Target
|
1680.60 |
1851.67 |
- |
10.18 |
buy
|
|
|
|
|
12 Nov 2025
|
Inventurus Knowledge
|
ICICI Securities Limited
|
1680.60
|
2000.00
|
1644.70
(2.18%)
|
19.01 |
Buy
|
|
|
We met IKS’ management at I-Sec conference. IKS is focusing on continuing the traction on full-platform deals, increasing cross-selling with AQuity clients, using AI to gain operating margin leverage and increase non-linearity between revenue and headcount growth and working with hospitals.
|
|
10 Mar 2025
|
Inventurus Knowledge
|
ICICI Securities Limited
|
1680.60
|
1820.00
|
1732.15
(-2.98%)
|
Target met |
Hold
|
|
|
IKS Health (IKS) is a Platform as a Service (PaaS) company that caters to US’ healthcare provider segment. It focusses on outsourcing the routine chores of physicians. IKS’ platform has 16 key features, spanning across chores in a physician’s value chain, bundled into admin offerings and clinical offerings.
|
|
12 Dec 2024
|
Inventurus Knowledge
|
Ashika Research
|
1680.60
|
|
|
|
IPO Note
|
|
|
|
|
11 Dec 2024
|
Inventurus Knowledge
|
SBI Securities
|
1680.60
|
|
|
|
IPO Subscribe
|
|
|
|
|
10 Dec 2024
|
Inventurus Knowledge
|
Ventura
|
1680.60
|
|
|
|
IPO Subscribe
|
|
|
|